Opportunity ID: 258188

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-PS15-1501
Funding Opportunity Title: Tuberculosis Elimination and Laboratory Cooperative Agreement (CoAg)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 62
Assistance Listings: 93.116 — Project Grants and Cooperative Agreements for Tuberculosis Control Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 3
Posted Date: Jun 20, 2014
Last Updated Date: Jul 23, 2014
Original Closing Date for Applications: Aug 20, 2014 Application Deadline: August 20, 2014, 11:59 p.m. U.S. Eastern Daylight Time.
Current Closing Date for Applications: Sep 04, 2014 Application Deadline: September 4, 2014, 11:59 p.m. U.S. Eastern Daylight Time.
Archive Date: Sep 19, 2014
Estimated Total Program Funding: $385,601,610
Award Ceiling: $8,304,252
Award Floor: $118,760

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Eligible Applicants:
Government Organizations:
•State or their bona fide agents (includes the District of Columbia)
•Territorial governments or their bona fide agents in the Commonwealth of Puerto Rico and the Virgin Islands
•Political subdivision of States (including the cities of Los Angeles, CA; San Francisco, CA; San Diego, CA; Houston, TX; Chicago, IL; Detroit, MI; New York City, NY; Philadelphia, PA; Baltimore, MD) or their bona fide agents, and in consultation with their state government.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of the Tuberculosis (TB) Elimination Cooperative Agreement (CoAg) funds is to assist the current efforts of state, local, and territorial TB programs to prevent, control, and eventually eliminate TB in the United States. Financial assistance is provided to TB programs to augment current local contributions for TB prevention and control activities; developing human resources through improved training, education, communications, and information dissemination; and strengthening laboratory capacity to ensure that timely and reliable TB laboratory services be available to healthcare providers and TB controllers.
Link to Additional Information: THIS IS NOT AN ACTIVE LINK. PLEASE CLICK ON THE WORDS “FULL ANNOUNCEMENT” AT THE TOP OF THIS PAGE.
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDC

Procurement and Grants Office (PGO)

Technical Information Management Section (TIMS)

Phone: 770-488-2700

Email:pgotim@cdc.gov

Version History

Version Modification Description Updated Date
The Application Instructions have been amended to include additional information and to extend the application deadline date. Jul 23, 2014
Updated Funding Opportunity Text Description. Jul 23, 2014
Jun 20, 2014

DISPLAYING: Synopsis 3

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-PS15-1501
Funding Opportunity Title: Tuberculosis Elimination and Laboratory Cooperative Agreement (CoAg)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 62
Assistance Listings: 93.116 — Project Grants and Cooperative Agreements for Tuberculosis Control Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 3
Posted Date: Jun 20, 2014
Last Updated Date: Jul 23, 2014
Original Closing Date for Applications: Aug 20, 2014 Application Deadline: August 20, 2014, 11:59 p.m. U.S. Eastern Daylight Time.
Current Closing Date for Applications: Sep 04, 2014 Application Deadline: September 4, 2014, 11:59 p.m. U.S. Eastern Daylight Time.
Archive Date: Sep 19, 2014
Estimated Total Program Funding: $385,601,610
Award Ceiling: $8,304,252
Award Floor: $118,760

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Eligible Applicants:
Government Organizations:
•State or their bona fide agents (includes the District of Columbia)
•Territorial governments or their bona fide agents in the Commonwealth of Puerto Rico and the Virgin Islands
•Political subdivision of States (including the cities of Los Angeles, CA; San Francisco, CA; San Diego, CA; Houston, TX; Chicago, IL; Detroit, MI; New York City, NY; Philadelphia, PA; Baltimore, MD) or their bona fide agents, and in consultation with their state government.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of the Tuberculosis (TB) Elimination Cooperative Agreement (CoAg) funds is to assist the current efforts of state, local, and territorial TB programs to prevent, control, and eventually eliminate TB in the United States. Financial assistance is provided to TB programs to augment current local contributions for TB prevention and control activities; developing human resources through improved training, education, communications, and information dissemination; and strengthening laboratory capacity to ensure that timely and reliable TB laboratory services be available to healthcare providers and TB controllers.
Link to Additional Information: THIS IS NOT AN ACTIVE LINK. PLEASE CLICK ON THE WORDS “FULL ANNOUNCEMENT” AT THE TOP OF THIS PAGE.
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDC

Procurement and Grants Office (PGO)

Technical Information Management Section (TIMS)

Phone: 770-488-2700

Email:pgotim@cdc.gov

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-PS15-1501
Funding Opportunity Title: Tuberculosis Elimination and Laboratory Cooperative Agreement (CoAg)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 62
Assistance Listings: 93.116 — Project Grants and Cooperative Agreements for Tuberculosis Control Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Jul 23, 2014
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Aug 20, 2014 Application Deadline: August 20, 2014, 11:59 p.m. U.S. Eastern Daylight Time.
Archive Date: Sep 19, 2014
Estimated Total Program Funding: $385,601,610
Award Ceiling: $8,304,252
Award Floor: $118,760

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Eligible Applicants:
Government Organizations:
•State or their bona fide agents (includes the District of Columbia)
•Territorial governments or their bona fide agents in the Commonwealth of Puerto Rico and the Virgin Islands
•Political subdivision of States (including the cities of Los Angeles, CA; San Francisco, CA; San Diego, CA; Houston, TX; Chicago, IL; Detroit, MI; New York City, NY; Philadelphia, PA; Baltimore, MD) or their bona fide agents, and in consultation with their state government.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of the Tuberculosis (TB) Elimination Cooperative Agreement (CoAg) funds is to assist the current efforts of state, local, and territorial TB programs to prevent, control, and eventually eliminate TB in the United States. Financial assistance is provided to TB programs to augment current local contributions for TB prevention and control activities; developing human resources through improved training, education, communications, and information dissemination; and strengthening laboratory capacity to ensure that timely and reliable TB laboratory services be available to healthcare providers and TB controllers.
Link to Additional Information: THIS IS NOT AN ACTIVE LINK. PLEASE CLICK ON THE WORDS “FULL ANNOUNCEMENT” AT THE TOP OF THIS PAGE.
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDC

Procurement and Grants Office (PGO)

Technical Information Management Section (TIMS)

Phone: 770-488-2700

Email:pgotim@cdc.gov

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-PS15-1501
Funding Opportunity Title: Tuberculosis Elimination and Laboratory Cooperative Agreement (CoAg)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 62
Assistance Listings: 93.116 — Project Grants and Cooperative Agreements for Tuberculosis Control Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jun 20, 2014
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Aug 20, 2014 Application Deadline: August 20, 2014, 11:59 p.m. U.S. Eastern Daylight Time.
Archive Date: Sep 19, 2014
Estimated Total Program Funding: $385,601,610
Award Ceiling: $8,304,252
Award Floor: $118,760

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Eligible Applicants:
Government Organizations:
•State or their bona fide agents (includes the District of Columbia)
•Territorial governments or their bona fide agents in the Commonwealth of Puerto Rico and the Virgin Islands
•Political subdivision of States (including the cities of Los Angeles, CA; San Francisco, CA; San Diego, CA; Houston, TX; Chicago, IL; Detroit, MI; New York City, NY; Philadelphia, PA; Baltimore, MD) or their bona fide agents, and in consultation with their state government.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The Centers for Disease Control and Prevention (CDC), Division of Tuberculosis Elimination (DTBE) is the lead Federal Agency for TB prevention and control (P&C) funding, resource coordination, and development and promulgation of national strategies and policies. As such, DTBE is continuing a 30-year strategy of federal involvement in funding essential elements in TB programs through a Cooperative Agreement (CoAg). The primary responsibility for designing and carrying out TB P&C activities rests with state and local health departments, not the Federal Government. This CoAg is intended to complement ongoing TB P&C and laboratory services and activities at the local and state level. It is not the intent of this CoAg to supplant, replace, or reduce state and local support for TB control activities and responsibilities (e.g., provision of medications, in-patient care, health department facilities).
DTBE distributes TB CoAg funds to support TB P&C activities, Human Resource Development (HRD) activities and Public Health Laboratory Services based on data-driven funding formulas to align the funding with the changing TB epidemiology in the United States. The formula to support P&C and HRD activities was developed in collaboration with the National TB Controllers Association (NTCA) and has been gradually phased in over time. Starting in 2015, 100% of funds will be allocated according to the funding formula.
Laboratory funding will be determined for each jurisdiction according to a workload-based formula. Laboratory funds are directed at ensuring high-quality laboratory testing with rapid turn-around-time (TAT) and improved efficiency in laboratory testing algorithms.
Certain populations are disproportionately affected by TB, such as persons with HIV infection or diabetes, persons experiencing homelessness, persons who are incarcerated, or persons who use illicit substances. The TB incidence rate among foreign-born persons in 2013 was approximately 12 times greater than the incidence rate among U.S.-born persons, and the percentage of TB cases occurring in foreign-born persons continues to increase, reaching 64.6% in 2013. Achieving TB elimination in the United States will involve focusing on persons in these risk groups.
Further priority should be focused on case clusters where genotype or field investigation information suggests recent transmission. For example, clusters involving homeless or incarcerated populations, or users of illicit substances, frequently involve recent transmission. Clusters with suspected recent transmission should be prioritized for intensified interventions to interrupt transmission.

Link to Additional Information: THIS IS NOT AN ACTIVE LINK. PLEASE CLICK ON THE WORDS “FULL ANNOUNCEMENT” AT THE TOP OF THIS PAGE.
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDC

Procurement and Grants Office (PGO)

Technical Information Management Section (TIMS)

Phone: 770-488-2700

Email:pgotim@cdc.gov

Folder 258188 Revised Full Announcement-1 -> PS15-1501 AMENDMENT I _7.22.14.pdf

Packages

Agency Contact Information: CDC
Procurement and Grants Office (PGO)
Technical Information Management Section (TIMS)
Phone: 770-488-2700

Email: pgotim@cdc.gov

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.116 NCHHSTP-NR NCHHSTP-NR PKG00199723 Jun 20, 2014 Sep 04, 2014 View

Package 1

Mandatory forms

258188 SF424-2.0.pdf

258188 SF424A-1.0.pdf

258188 HHS_CheckList-1.1.pdf

258188 Project-1.1.pdf

258188 Budget-1.1.pdf

Optional forms

258188 Other-1.1.pdf

2025-07-09T13:59:44-05:00

Share This Post, Choose Your Platform!

About the Author: